Imatinib Mesylate (STI571) is an orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM, respectively.A c-Abl, PDGFR, and c-kit inhibitor.
Specifications and Purity: ≥99%
MDL Number: MFCD04307699
Molecular Formula: C30H35N7O4S
Molecular Weight: 589.71
PubChem CID: 123596
Isomeric SMILES: CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O
Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/I129225-SCI_31da25c10bf13aa50d9a1f150ed25a2c.pdf
- UPC:
- 41105701
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- I129225-250mg
- CAS:
- 220127-57-1
- Product Size:
- 250mg
- Hazard Statement Codes:
- H351:H302
- Precautionary Statement Codes:
- P501:P405:P301+P312:P330:P280:P270:P264
akash.verma@cenmed.com
(732) 447-1115





